TP53 and leiomyosarcoma: Using this approach, TgPTTG/p53+/− animals resulted in earlier tumor development than PTTG or p53+/− alone (Figure 13) and increased the incidence of high grade leiomyosarcomas from 7% in p53+/− mice to 14% in TgPTTG/p53+/−.